Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1097/JU.0000000000004123 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
In Response to: Reconsider the Indication of Implantable Cardioverter Defibrillator in Patients With Cardiac Amyloidosis.
J Cardiovasc Electrophysiol
December 2024
Department of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota, USA.
Terminology controversies.
Alzheimers Dement
December 2024
Department of Radiology, Mayo Clinic, Rochester, Minnesota, USA.
Outcome of Splenectomy in JAK2 Inhibitor Treated Patients With Myelofibrosis: A Mayo Clinic Experience in 34 Consecutive Cases.
Am J Hematol
December 2024
Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, Minnesota, USA.
Psychedelic Therapeutics for Adolescents: Safety, Opportunities, and Equipoise.
J Am Acad Child Adolesc Psychiatry
December 2024
Mayo Clinic College of Medicine and Science, Rochester, Minnesota.
Peri-Implant Enhancement of the Breast: Imaging Features, Significance, and Management Strategies.
J Breast Imaging
December 2024
Division of Plastic and Reconstructive Surgery, Mayo Clinic in Florida, Jacksonville, FL, USA.
Objective: Peri-implant enhancement can be seen on contrast-enhanced breast MRI, but its association with malignancy has not been described, leading to considerable variability in assessment and recommendations by radiologists. This study evaluated imaging features, management, and outcomes of implant-related enhancement.
Methods: This multisite IRB-approved retrospective review queried all breast MRI reports for keywords describing peri-implant enhancement, fluid, and/or masses (plus synonymous descriptions) and implant-associated malignancies, with subsequent imaging and chart review.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!